Charles River Laboratories | CRL - 股票



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 10.82B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


股票 更改 日
Agilent USD 1.09B 30M 2026-03
Align Technology USD 214.94M 11.4M 2026-03
Bio-Rad Laboratories USD 770.5M 29.8M 2026-03
Bruker USD 1.12B 26.9M 2026-03
Cardinal Health USD 18.01B 2.11B 2026-03
Charles River Laboratories USD 359.72M 60.62M 2026-03
Cigna USD 5.83B 1.51B 2026-03
CVS Health USD 17.77B 1.48B 2026-03
Danaher USD 2.61B 119M 2026-03
Dentsply International USD 659M 17M 2026-03
Elevance Health USD 0 0 2024-12
Illumina USD 611M 47M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Intrexon USD 287K 68K 2022-12
Laboratory Of America USD 497.7M 37M 2026-03
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Lonza CHF 1.68B 163M 2025-12
McKesson USD 24.21B 2.86B 2026-03
Merck EUR 4.56B 52M 2025-12
Mettler Toledo International USD 404.83M 17.6M 2026-03
Novartis USD 6.29B 17M 2026-03
Pfizer USD 10.67B 13M 2026-03
Quest Diagnostics USD 225M 36M 2026-03
Revvity USD 387.5M 8.01M 2026-03
Thermo Fisher Scientific USD 5.5B 71M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
UnitedHealth USD 280M 280M 2023-12
Waters USD 1.5B 923.63M 2026-03
West Pharmaceutical Services USD 452.6M 8.7M 2026-03